These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement. Gow SM; Caldwell G; Toft AD; Seth J; Hussey AJ; Sweeting VM; Beckett GJ J Clin Endocrinol Metab; 1987 Feb; 64(2):364-70. PubMed ID: 3793854 [TBL] [Abstract][Full Text] [Related]
9. Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement? Fraser WD; Biggart EM; O'Reilly DS; Gray HW; McKillop JH; Thomson JA Br Med J (Clin Res Ed); 1986 Sep; 293(6550):808-10. PubMed ID: 3094667 [TBL] [Abstract][Full Text] [Related]
10. The effects of thyroid status on plasma leptin levels in women. Ozata M; Ozisik G; Bingol N; Corakci A; Gundogan MA J Endocrinol Invest; 1998 Jun; 21(6):337-41. PubMed ID: 9699123 [TBL] [Abstract][Full Text] [Related]
11. Comparative studies on the in vitro uptake of labelled 1-thyroxine and 1-triiodothyronine by human erythrocytes in hyperthyroidism and hypothyroidism. FRIIS T Dan Med Bull; 1960 Jul; 7():89-95. PubMed ID: 13825229 [No Abstract] [Full Text] [Related]
12. Effects of hypothyroidism and hyperthyroidism on serum glycoproteins in experimental rats. Uniyal BP; Singh LR; Nagpal KK Indian J Exp Biol; 1998 Feb; 36(2):148-51. PubMed ID: 9754042 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients. Nedvídková J; Felt V Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434 [TBL] [Abstract][Full Text] [Related]
15. Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Nanda N; Bobby Z; Hamide A; Koner BC; Sridhar MG Metabolism; 2007 Oct; 56(10):1350-5. PubMed ID: 17884444 [TBL] [Abstract][Full Text] [Related]
16. Plasma levels of NT-pro-brain natriuretic peptide in patients with overt and subclinical hyperthyroidism and hypothyroidism. Pakuła D; Marek B; Kajdaniuk D; Krysiak R; Kos-Kudła B; Pakuła P; Gatnar A; Borgiel-Marek H; Nowak M; Siemińska L; Głogowska-Szeląg J; Ostrowska Z Endokrynol Pol; 2011; 62(6):523-8. PubMed ID: 22144219 [TBL] [Abstract][Full Text] [Related]
17. [The "acute" disappearance of radiothyroxine from the blood of normal, hyperthyroid and hypothyroid subjects]. Busnardo B; Guido R; Vianello A; Casson F; Varotto L Acta Isot (Padova); 1968; 8(3):251-69. PubMed ID: 4901484 [No Abstract] [Full Text] [Related]
18. [Importance of the determination of free thyroxine and triiodothyronine serum levels in preclinical hyperthyroidism and subclinical hypothyroidism]. Földes J; Bános C; Lakatos P; Váradi A; Gara A; Istvánffy M Orv Hetil; 1986 Jun; 127(22):1315-9. PubMed ID: 3014422 [No Abstract] [Full Text] [Related]
19. Plasma atriopeptin concentrations in hyperthyroidism, euthyroidism, and hypothyroidism: studies in man and rat. Ladenson PW; Langevin H; Michener M J Clin Endocrinol Metab; 1987 Dec; 65(6):1172-6. PubMed ID: 2960689 [TBL] [Abstract][Full Text] [Related]
20. Influence of thyroid status on serum immunoreactive leptin levels. Valcavi R; Zini M; Peino R; Casanueva FF; Dieguez C J Clin Endocrinol Metab; 1997 May; 82(5):1632-4. PubMed ID: 9141562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]